ResearchNet - RechercheNet

• Search Again

• Back to Results

• Print Preview Opens in a new window

• Watch this Opportunity

• Notify a Colleague

Funding Opportunity Details

Funding Organization Canadian Institutes of Health Research Program Name Team Grant
:

        GACD 2026: NCD Multi Sectors (Implementation Science to Tackle Non-Communicable Diseases: Maximizing Collaboration and Coordination Beyond Healthcare Systems) **Sponsor(s)** The Canadian Institutes of Health Research (CIHR), in partnership with the Institute of Population and Public Health (IPPH), the Institute of Circulatory and Respiratory Health (ICRH), and the Global Alliance for Chronic Diseases (GACD).

Program Launch Date 2026-03-18

Important Dates

| Competition | Stage 1 Application to GACD (2026/06/17) and CIHR (2026/06/23) (202606NML) | Stage 2 Application to GACD (2026/10/20) and CIHR (2026/10/22) (202610NMS) |
| --- | --- | --- |
| Application Deadline | 2026-06-23 | 2026-10-22 |
| Anticipated Notice of Decision | 2026-09-28 | 2027-03-04 |
| Funding Start Date | N/A | 2027-01-01 |

---

Notices

The GACD stage 1 and stage 2 application deadlines are at 5 p.m. London Time / 6 p.m. Brussels Time.

The CIHR stage 1 and stage 2 application deadlines are at 8 p.m. Eastern Standard Time (EST).

Webinar

The GACD Secretariat has made available resources to provide guidance on applying to this call.

Partner Linkage Tool

GACD has developed a collaborator forum to assist applicants in identifying project partners.

Co-funding

Applicants interested in discussing their eligibility for co-funding from participating GACD member agencies should contact the GACD Secretariat as soon as possible.

---

Table of Contents

• Description
• Objectives
• Eligibility
• Guidelines
• Review Process and Evaluation
• How to Apply
• Contact Information
• Sponsor Description
• Additional Information

---

Description

This funding opportunity is part of the 11th call for applications of the Global Alliance for Chronic Diseases (GACD). The aim of this call is to fund implementation research focused on strategies leveraging opportunities provided by settings and sectors with and beyond the healthcare system to tackle chronic non-communicable diseases (NCDs) in low- and middle-income countries (LMICs) and/or underserved populations, including Indigenous populations in high-income countries (HICs). CIHR-funded projects with a focus on NCDs in Indigenous communities in Canada are eligible.

Established in 2009, GACD brings together major international research funding agencies specifically to address the growing burden of NCDs in LMICs and in underserved groups experiencing health inequities,  such as Indigenous Populations in HICs, by building evidence to inform national and international NCD policies and contribute to the achievement of the United Nations Sustainable Development Goals under section 3.4. Reducing the burden of NCDs is critical to building more resilient, equitable, and healthier societies, and is recognized as a key impact area in the CIHR Framework for Action on Global Health Research.

Global recognition of the social and structural determinants of NCDs points to additional opportunities to prevent and manage NCDs by leveraging opportunities provided by settings and sectors beyond the formal healthcare system.

Implementing innovative measures to tackle NCDs will also require partnerships with communities and non-government sectors (including NGOs, civil society, foundations, community enterprises, and faith-based organisations) to offer flexible and supportive delivery of resources and environments. These partnerships and efforts may help foster stronger engagement of individuals, communities and populations underserved by the healthcare system due to inequities/differences in access, education, health beliefs, attitudes, geography, language or other factors. While the focus is on settings outside of the healthcare system, collaboration with the relevant healthcare system(s) as part of the project is expected to facilitate effective design and knowledge mobilization.

Applicants should review the definition of terms in the call glossary to ensure that their proposed project is within scope. For complete information on the challenge to be addressed, scope and expected impact of the research, please refer to the GACD call.

Research Areas

This funding opportunity will support projects relevant to the following research areas:

Priority Research Area (ICRH Pool): Reimagine Circulatory and Respiratory NCD Care

• Projects in this pool must be relevant to the ICRH mandate and strategic vision, and address the pre-acute and/or post-acute phases of NCDs in an integrated approach in collaboration with and/or beyond the healthcare system. ICRH will also support research that explores care transitions between community and healthcare settings.

• Examples of proposals that could be supported include, but are not limited to:

  • Pre-acute phase: Interventions addressing social, behavioral and biological risk factors for NCDs, e.g., community-based programs for hypertension, digital tools for early detection of cardiovascular risk, remote screening for atrial fibrillation, smoking prevention and cessation in workplaces and schools, lifestyle interventions for vascular health, mobile clinics/paramedics for resuscitation delivery for out-of-hospital cardiac arrest, workplace interventions for sleep hygiene.
  • Post-acute phase: Interventions addressing rehabilitation, secondary prevention and ongoing management of NCDs to prevent recurrence and maintain quality of life e.g. cardiac rehabilitation models in underserved areas, strategies for long-term medication adherence, pulmonary rehabilitation programs, digital tools for respiratory disease follow-up, rehabilitation strategies for cognitive and motor recovery following stroke. Priority Research Area (IPPH Pool): NCD Prevention and Health Promotion

• Projects in this pool must be relevant to the IPPH mandate and mission, must meaningfully address health equity *, and focus on health promotion or primary prevention of NCDs outside the formal healthcare system.

Equity is the absence of unfair, avoidable or remediable differences among groups of people, whether those groups are defined socially, economically, demographically, or geographically or by other dimensions of inequality (e.g. sex, gender, ethnicity, disability, or sexual orientation). Health equity is achieved when everyone can attain their full potential for health and well-being.
The following types of projects will *NOT** be funded:

• Proposals with the primary aim of informing the development and/or selection of an intervention for a given context, where the implementation component will be explored in a future project (i.e. standalone feasibility projects).
• Studies that cannot feasibly be completed in the life cycle of the grant (typically limited to three to five years, depending on the funding agency).
• Etiological work, mechanistic, or epidemiological research, including epidemiological cohorts, unless an essential component of a focused study to develop implementation research approaches.
• Clinical trials, validation studies, or intervention efficacy studies for a new or established pharmacological agent or behavioural intervention. For key requirements that should be included in all proposals, please refer to the GACD call.

For specific considerations for GACD applications, please refer to the GACD call.

Co-Funding

Through engagement in the GACD, CIHR is aligning their global health research investments with other international health research funding organizations. The GACD model enables direct collaboration between CIHR and other participating GACD members through the co-funding of individual research projects. GACD funding opportunities encourage applicants to consider applying for co-funding from two or more participating GACD member agencies. Applicants interested in applying for co-funding should contact funding@gacd.org as soon as possible.

Additional Considerations

Equity, Diversity and Inclusion and Indigenous Rights

CIHR is committed to promoting the inclusion and advancement of groups historically excluded from science as one of the means to enhance excellence in research, training and knowledge mobilization. This means recognizing and reducing systemic barriers, mitigating biases, as well as including and benefiting from the full pool of talented researchers and trainees in the system. CIHR's position on equity, diversity and inclusion (EDI) is available in the Tri-Agency Statement on Equity, Diversity and Inclusion.

CIHR recognizes that First Nations, Métis and Inuit are rights-holding as First Peoples of Canada and may not consider themselves to be part of equity-denied groups (e.g., women, racialized minorities, persons with disabilities and members of 2SLGBTQI+ communities). Taking a rights – and distinctions-based approach to Indigenous self-determination in research is important to reflect this position and to strengthen Indigenous health and well-being. CIHR's commitment to supporting Indigenous self-determination in health research is available in the CIHR Strategic Plan 2021-2031 and the Action Plan: Building a healthier future for First Nations, Inuit, and Métis Peoples.

Role and Contributions of Applicant Partners: CIHR recognizes that a broad range of partners may be relevant to this opportunity and it is expected that applicant(s) describe the role of all applicant partners and how/if they will contribute to research and research related activities. Any consideration of risk and/or conflict of interest should also be explained, as appropriate.

Funds Available

CIHR and partner(s) financial contributions are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or decrease due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.

• The total amount available for this funding opportunity is $3,000,000, enough to fund approximately three (3) grants. This amount may increase if additional funding partners participate. The maximum amount per grant is $200,000 per year for up to five (5) years, for a total of $1,000,000 per grant.
• Of this $3,000,000:
  • $1,000,000 is available to fund one (1) application relevant to the ICRH Pool: Reimagine Circulatory and Respiratory NCD Care
  • $2,000,000 is available to fund two (2) applications relevant to the IPPH Pool: NCD Prevention and Health Promotion
• The top-rated application/s (in the fundable range) relevant to each funding pool will be funded. For more information on the appropriate use of funds, refer to Allowable Costs.

Top

---

Objectives

This funding opportunity supports implementation research focused on strategies leveraging opportunities provided by settings and sectors beyond the health system in LMICs and/or underserved populations, including Indigenous populations, in HICs.

The projects funded under this call will collectively:

• contribute to the United Nations Sustainable Development Goal 3.4 to reduce premature mortality from NCDs by one third by 2030;
• address implementation of strategies across sectors that will:
  • provide evidence and recommendations to national programmes and policies; aiming to inform policy and practice to address the growing burden of NCDs.
  • expand accessibility of programmes addressing NCDs.
  • promote the early prevention, risk reduction, and timely diagnosis of NCDs.
  • ensure continuity of care for NCDs, from prevention and screening to management in the community.
  • promote improved health outcomes in underserved populations, and low-and middle-income countries.
  • improve quality of life across the life course and extend healthy life expectancy.
  • improve local capacity for implementation research, data collection and harmonisation, and stakeholder engagement for strategies leveraging sectors beyond the health system to tackle non-communicable diseases. While the focus is on settings outside of the healthcare system, collaboration with the relevant healthcare system(s) as part of the project is expected to facilitate effective design and knowledge mobilization.

Top

---

Eligibility

Eligibility to Apply

For an application to be eligible, all the requirements stated below must be met:

1. The Nominated Principal Applicant (NPA) must be a Canada-based NPA who is
   1. An independent researcher affiliated with a Canadian postsecondary institution and/or its affiliated institutions (including hospitals, research institutes and other non-profit organizations with a mandate for health research and/or knowledge translation).

OR (only applicable to projects involving Indigenous Peoples in Canada)
2. An individual affiliated with an Indigenous non-governmental organization in Canada with a research and/or knowledge translation mandate.

OR (only applicable to projects involving Indigenous Peoples in Canada)
3. An Indigenous non-governmental organization in Canada with a research and/or knowledge translation mandate.
2. The NPA must have their substantive role in Canada for the duration of the requested grant term.
3. The Institution Paid for the Canada-led application receives and administers the funds on behalf of the NPA and therefore must be authorized by CIHR before the funds can be released.
4. If the NPA is not an independent researcher, the team must include at least one Canada-based independent researcher listed as Principal Applicant (PA).
5. The team must include at least one (1) team member, other than the NPA, who is an early career researcher identified on the application as a Co-Applicant.
6. In addition, Canada–LMIC teams must include the following participants from each LMIC in which research will be conducted (LMIC status as defined by the World Bank).
1. At least one independent researcher listed as Principal Applicant;
AND
2. At least one decision maker and/or policy maker listed as Principal Knowledge User or Knowledge User.
7. If the project involves Indigenous Health Research, the team must also include:
1. The following participants from Canada where Indigenous Health Research will be conducted:
1. At least one team member listed as NPA or Principal Applicant who self-identifies as Indigenous (First Nations, Inuit or Métis) or can provide evidence of having meaningful and culturally safe involvement with Indigenous communities (First Nations, Inuit and/or Métis), or both (see How to Apply for more details);
AND
2. At least one Indigenous Elder and/or Indigenous Knowledge Keeper* (First Nations, Inuit or Métis) OR a knowledge user who is affiliated with an Indigenous non-governmental organization in Canada with a research and/or knowledge translation mandate listed as NPA, Principal Knowledge User, or Knowledge User.
AND
2. The following participants from each country other than Canada where Indigenous Health Research will be conducted:
1. At least one independent researcher listed as a Principal Applicant who self-identifies as Indigenous or can provide evidence of having meaningful and culturally safe involvement with Indigenous communities, or both (see How to Apply for more details);
AND
2. At least one Indigenous Elder and/or Indigenous Knowledge Keeper; *OR** a knowledge user who is affiliated with an Indigenous non-governmental organization with a research and/or knowledge translation mandate listed as a Principal Knowledge User or Knowledge User.
*A Knowledge Keeper (also known as a Knowledge Holder or Knowledge Guardian) is an Indigenous person, regardless of age, who possesses the Indigenous cultural knowledge necessary for the proposed research project or activities, as recognized, validated, and authenticated by the Indigenous community.
8. If this research involves populations living in conditions of vulnerabilities in Canada, the team must also meet the eligibility criteria below:
1. The team must include at least one team member (either independent researcher or decision maker and/or policy maker), other than the NPA, from the involved community(ies) listed as Principal Applicant or Principal Knowledge User.
CIHR encourages joint applications involving team members from more than one GACD member country and will support successful applications through co-funding between the appropriate funding agencies. Applicants will be required to meet the eligibility criteria for the relevant funding agencies and the agency's specific funding conditions. Please refer to the GACD call for the specific agencies' eligibility criteria and contact the GACD Secretariat as soon as possible if you are interested in discussing your eligibility for co-funding.

Top

---

Guidelines

General CIHR Policies

Before submitting an application to this funding opportunity, applicants should review the relevant policies and guidelines on the CIHR Funding Policies page, including the CIHR Application Administration Guide – Part 2 General Requirements for Grants and Awards Applications, to ensure understanding of their roles and responsibilities.

Research Security

The Policy on Sensitive Technology Research and Affiliations of Concern (STRAC Policy) is applicable to this funding opportunity. Consult the Tri-agency guidance on the STRAC Policy for more information.

Allowable Costs

Applicants are advised to consult the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Guide on Financial Administration (TAGFA) to determine if an expenditure is an appropriate use of grant funds.

To further clarify, the following expenses are examples of appropriate uses of grant funds, provided they satisfy the principles and pertinent directives of the TAGFA:

• Release Time Allowance to facilitate the participation of knowledge users, who meet TAGFA compensation requirements, in the research project.
• Expenses related to accessibility support(s) considered necessary for the NPA or members of the applicant team to carry out the project and engage with persons with disabilities (e.g. specialized equipment, support services, compensation, and alternate document format(s). This excludes costs for accessibility support(s) offered as standard provision(s)/service(s) of the employer institution to their research personnel.
• Expenditures that respect the culture and traditions of Indigenous peoples, where needed for the meaningful conduct of research. See TCPS 2 - Chapter 9 Research Involving the First Nations, Inuit and Métis Peoples of Canada and TAGFA Directive on Gifts, Honoraria and Incentives. These include:
  • Costs related to community mobilization and engagement, including culturally relevant promotional items such as, tobacco, cloth, feasting and gift giving for honoring ceremonies, and cash reimbursements (in a method acceptable to the individual or community being reimbursed) to compensate community participation.
  • Contracts and/or consultant fees for knowledge translation and communication activities for Indigenous Elders, community members, and Indigenous Knowledge Keepers involved in activities related to the Indigenous community. Use of Personal Information

All information is shared in accordance with the Privacy Act. As per the Privacy Act, personal information means information about an identifiable individual that is recorded in any form.

• Personal information submitted during the application process, including but not limited to information provided through applicant CVs, the Tri-agency Self-identification Questionnaire and other application documents required by this funding opportunity, will be made available to select  CIHR personnel with the appropriate training and security clearance and on a need-to-know basis, for the purposes of future program planning and design and evaluation and learning for organizational and program strengthening. In addition, CIHR may share de-identified, aggregated self-identification information with the sponsoring institutes and competition partners, for this purpose. For further information about the Self-identification Questionnaire and the use of personal information, see the Tri-agency Self-identification Questionnaire Frequently Asked Questions.
• The following information submitted to CIHR at Stage 1 will be shared with the proposed institution paid for planning purposes: name of the NPA (and other applicants, if provided), application number, title of the proposal and requested budget.
• For this funding opportunity, some sections of the application containing information that directly or indirectly identifies the applicant(s), will be shared with some funding partner(s) and/or CIHR Institute staff, to assist with relevance review and funding decisions.
• Personal information, including related research security forms, collected as part of the implementation of the research security measures, may be shared with Canada's national security departments and agencies for the purpose of assessing risks to national security.
• All research reports (annual/progress/final) provided to CIHR will be shared with partners supporting the grant (See Conditions of Funding for report details). Conditions of Funding

In addition to the general conditions of funding governing CIHR grants, the following are the program specific conditions of funding applicable to this funding opportunity:

• Data related to First Nations, Inuit or Métis communities whose traditional and ancestral territories are in Canada must be managed in accordance with data management principles developed and approved by those communities, and on the basis of free, prior and informed consent. This includes, but is not limited to, considerations of Indigenous data sovereignty, as well as data collection, ownership, protection, use, and sharing.
• All information intended for public consumption, including for the purposes of informing and engaging partners (e.g., website content, information pamphlets, guidelines, promotional and event-related material, etc.), must be provided in both official languages (English and French), accessible to screen readers, and should be developed using plain language practices. See Allowable Costs for more details.
• CIHR is a signatory to the World Health Organization's Joint Statement on Public Disclosure of Results from Clinical Trials ("WHO Joint Statement") requiring all clinical trials to be registered and the results disclosed publicly in a timely manner. For more information, please consult the CIHR Policy Guide - Requirements for Registration and Disclosure of Results from Clinical Trials.
• CIHR reserves the right to terminate or suspend funding if there is a determination of unacceptable national security risk by the Government of Canada.
• Applicants must budget for the costs of having two team members participate in the annual three-day face-to-face meeting of the GACD Research Network (location to vary annually) during each year of the project.
  • Attendance at the meetings is mandatory for two team members, with at least one of whom is based in an LMIC or HIC (populations facing conditions of vulnerability). Teams are strongly encouraged to include one junior team member in each annual meeting.
  • The annual Network meeting supports GACD's aim to coordinate research in order to enhance knowledge exchange and maximize the potential for learning across the Network and the impact of the initiative.
• Where applicable, projects are expected to harmonize and standardize their data collection and exchange data.
• Funding applications submitted to the GACD will be held in jurisdictions outside of Canada and will not be subject to the provisions of the Privacy Act. Information submitted to the GACD as part of the applications will be governed by the provisions under UK data protection legislation.
• The Nominated Principal Applicant (NPA) is responsible for the following reporting requirements:
  • Annual manual reports. The template and instructions for this report will be provided by GACD. Completed reports must be provided to GACD and to the CIHR Contact Centre.
  • An electronic Final Report. This online report will be made available to the NPA on ResearchNet at the beginning of the grant funding period and can be filled in as the research progresses. The electronic Final Report may be shared with GACD.

Top

---

Review Process and Evaluation

Relevance Review Process

CIHR-IPPH and CIHR-ICRH will perform a relevance review on the Stage 1 applications using the Summary of Research Proposal and Relevance Form to identify applications that are in alignment with the objectives and research areas of this funding opportunity.

Stage 1 applications that are not deemed to be relevant will be withdrawn from the competition.

Review Process

For detailed information on the review process, please refer to the GACD call.

Briefly, GACD will coordinate a two-stage peer review process. First, a joint external international review committee will evaluate the Stage 1 applications; successful shortlisted applicants will be invited to submit more detailed Stage 2 applications.

Committee members will be selected based on suggestions from various sources including CIHR Institute(s)/branch(es), and partner(s), and align with the Conflict of Interest and Confidentiality Policy of the Federal Research Funding Organizations.

CIHR will ensure that any application that focuses on Indigenous Peoples' health will be reviewed by individuals with appropriate expertise including Indigenous ways of knowing and the Tri-Council Policy Statement 2 (TCPS 2) - Chapter 9 Research Involving the First Nations, Inuit and Métis Peoples of Canada.

Evaluation Criteria

For information on the evaluation criteria, please refer to the GACD call.

Funding Decision

Upon completion of the Stage 2 review process, CIHR will receive the ranking list, scores and recommendations on funding level and grant term for the applications that fall in the fundable range. The list will be used for funding decision-making purposes.

The top-rated applications (in the fundable range) relevant to the ICRH Pool and IPPH pool will be funded. In cases of tied scores within each funding pool, funding priority will be given to applications requesting co-funding from participating GACD members.

Within the context of applications requesting co-funding from participating GACD members, funding decisions will be subject to budgetary considerations, including potential budget reductions, with the goal of optimal usage of the available budget. If a GACD member participating in the co-funding model is not able to contribute because funds have already been spent, the next in line application with funding from all available sources may be funded.

The names of successfully funded applicants will be published on the CIHR and GACD websites.

Partner and Internal Collaborator Participation

The opportunity to add new partners and internal collaborators to this funding opportunity may arise after publication. These partners and internal collaborators may not be listed; however, the principles that govern relevance review, including consent to share information and funding decisions, will still apply.

Top

---

How to Apply

• The application process for this funding opportunity is comprised of four stages: 1a) Stage 1 application to GACD; 1b) Stage 1 application to CIHR; 2a) Stage 2 application to GACD; and 2b) Stage 2 application to CIHR.
  Stage 1a – Application to GACD:

• Stage 1 applications must be submitted in English only to GACD. For more information, consult the GACD call.
  Stage 1b – Application to CIHR:

• In addition to the Stage 1 application to GACD, the NPA must also complete a CIHR Stage 1 application (in one of the two official languages of Canada) and submit it using ResearchNet.

• To complete your CIHR Stage 1 application, follow the "Specific Instructions" listed below and where applicable, consult the Grants – Application Guidelines.

• Note that a Stage 1 application must be submitted to CIHR to be eligible to submit a Stage 2 application. All applications submitted at Stage 2 must have been successful at Stage 1; all other applications will be withdrawn from the competition and not sent to peer review.

• All participants listed, with the exception of Collaborators, are required to:

  • Have/obtain a CIHR PIN
  • Complete the Tri-Agency Self-identification Questionnaire.

• Organizations applying as Nominated Principal Applicants for the first time must contact CIHR's Contact Centre for guidance in creating a ResearchNet account and registering for a CIHR PIN.
  Specific instructions to complete your ResearchNet Stage 1 Application

**Please note that you must attach your GACD stage 1 application pdf (which includes participants CVs and the Research Proposal)* as an "Other" document in the CIHR Task: Attach Other Application Materials below. Therefore, no additional CVs are required in the CIHR Task: Identify Participants and no Research Proposal is required in the CIHR Task: Enter Proposal Information.***

Task: Identify Participants

• List all known participants in the "Identify Participants" task. Consult the Eligibility section and ensure that all requirements are met.
• The Nominated Principal Applicant must remain unchanged between Stage 1 and Stage 2 of the competition.
  • If the Canada-based NPA is not an independent researcher, the Canada-based independent researcher PA must additionally remain unchanged between the two stages (i.e., Stage 1 and Stage 2).
  • If the Nominated Principal Applicant is a non-governmental organization, then the organization's ResearchNet account must be used to open the Stage 1 application.
• Other participants may be included and can be added or removed between the two stages (i.e., Stage 1 and Stage 2).

• No additional CVs are required in this task.
  Task: Enter Proposal Information

• Complete the Overview, Details, and Descriptors sections.

• A Research Proposal is not required in this task.
  Task: Complete Summary of Research Proposal

• The summary must describe how the research proposal is in alignment with the objectives and research areas of this funding opportunity. Note that your summary cannot exceed 3,500 characters (including spaces) or approximately one (1) page.

• You must indicate your intention to apply for co-funding through another GACD partner (if applicable).
  Task: Enter Budget Information

• Complete the Budget Module in ResearchNet for the total requested budget following the task specific instructions outlined in the Grants – Application Guidelines.

• Financial Assistance Requested Details:

  • Provide a detailed budget justification in relation to planned activities and clearly justify all budget items (including cash and cash equivalent contributions, if relevant). Task: Attach Other Application Materials

Other – attach the following under "Other":

• Label as: "GACD Stage 1 Application" (mandatory, maximum 3 documents – maximum 99 pages per document): attach the complete GACD Stage 1 application pdf file.
• Indigenous Experience (mandatory for applications involving Indigenous Peoples, **maximum 1 document) – label as "Indigenous Experience – Name":**
  • For applications involving Indigenous Peoples in Canada and, if applicable, in each country where Indigenous Health Research will be conducted, teams must include at least one team member from each country who self-identifies as Indigenous (In Canada, First Nations, Inuit or Métis) or provides evidence of having meaningful and culturally safe involvement with Indigenous Peoples, or both (see Eligibility 7a).The team must therefore submit a one (1)-page attachment per country describing how they meet this requirement.

• Label as: "Suggested Reviewers" (mandatory, maximum 1 document):

  • In table format, provide a minimum of five suggested reviewers who have relevant expertise to review your proposed work and who would not be in conflict of interest with your application. Include their full name, country, affiliation, and current email address. Participant Table (mandatory) – upload as "Participant Table"

• Download and complete the Participant Table for all applicant team members (including Collaborators).

  • Note: When completing this section, applicants must protect the privacy and confidentiality of all individuals. How an individual self-identifies is personal and confidential information, which should not be disclosed without consent.

• You must indicate your intention to apply for co-funding through another GACD partner (if applicable).
  Letters of Support (optional):

• Signed letters of support from the community are encouraged. Please review the Writing Letters of Support document for guidance.
  Task: Apply to Priority Announcements/Funding Pools (mandatory)

• Select the funding opportunity title under the "Priority Announcement/Funding Pool Title" drop-down list, then select the Research Area under the "Relevant Research Area" drop-down list: 1) ICRH Pool and/or 2) IPPH Pool

  • Funding pools should be selected based on priority order (i.e., most relevant under funding pool number 1).

• The information in your Relevance Form must clearly describe (in one half-page) how the objectives of your proposed activity align with the selected funding pool(s). A separate Relevance Form will be required for each funding pool selected.
  Task: Manage Access (optional)

• The Nominated Principal Applicant (NPA) can delegate access to a maximum of five individuals to support the completion of the application. Note: A delegate's access does not carry over from one stage of the competition to another (i.e., from the registration to the application stage). The NPA will need to delegate access at each stage of a competition. NPAs should revoke delegates' access prior to completing the Consent and Submit tasks if they do not want them to retain access to submitted applications via their Completed Activities tab. For more information, please see the Frequently Asked Questions (FAQ).
  Stage 2a – Stage 2 Application to GACD:

• Invitations to submit a Stage 2 application are expected to be sent September 2026 by GACD.

• Stage 2 applications must be submitted in English only to GACD. For more information, consult the GACD call.
  Stage 2b – Stage 2 Application to CIHR:

• In addition to the Stage 2 application to GACD, the NPA invited to submit a Stage 2 application to GACD must also complete a CIHR Stage 2 application (in one of the two official languages of Canada) and submit it using ResearchNet.

• To complete the CIHR Stage 2 application, follow the "Specific Instructions" listed below and, where applicable, consult the Grants – Application Guidelines.

• All participants listed, with the exception of Collaborators, are required to:

  • Have/obtain a CIHR PIN
  • Complete the Tri-Agency Self-identification Questionnaire.

• Organizations applying as Nominated Principal Applicants for the first time must contact CIHR's Contact Centre for guidance in creating a ResearchNet account and registering for a CIHR PIN.
  Specific instructions to complete your ResearchNet Stage 2 Application:

**Please note that you must attach your GACD stage 2 application pdf (which includes participants CVs and the Research Proposal)* as an "Other" document in the CIHR Task: Attach Other Application Materials below. Therefore, no additional CVs are required in the CIHR Task: Identify Participants and no Research Proposal is required in the CIHR Task: Enter Proposal Information.***

Task: Identify Participants

• List all known participants in the "Identify Participants" task. Consult the Eligibility section and ensure that all requirements are met.
• The Nominated Principal Applicant must remain unchanged between Stage 1 and Stage 2 of the competition.
  • If the Canada-based NPA is not an independent researcher, the Canada-based independent researcher PA must additionally remain unchanged between the two stages (i.e., Stage 1 and Stage 2).
  • If the Nominated Principal Applicant is a non-governmental organization, then the organization's ResearchNet account must be used to open the Stage 1 application.
• Other participants may be included and can be added or removed between the two stages (i.e., Stage 1 and Stage 2).

• No additional CVs are required in this task.
  Task: Enter Proposal Information

• Complete the Overview, Details, and Descriptors sections.

• A Research Proposal is not required in this task.
  Task: Identify Sensitive Technology Research Areas

• If the research grant will aim to advance any of the listed Sensitive Technology Research Areas, the applicant must answer "Yes" to the screening question.

• All researchers with named roles in the research grant must review the List of Named Research Organizations, and are individually required to complete the Attestation form.

• The NPA must combine all attestation forms into one (1) PDF file and upload it under this task.

• Completed attestation forms will be neither accessible to, nor shared with, peer reviewers.

• CIHR will use this information to ensure applicants are compliant with the Government of Canada's policy on Sensitive Technology Research and Affiliations of Concern.

• For resources to assist in completing the Attestation form, please consult the Sensitive Technology Research and Affiliations of Concern, the Tri-agency guidance on the Policy on Sensitive Technology Research and Affiliations of Concern (STRAC Policy); and CIHR Research Security.
  Task: Complete Summary of Research Proposal

• The summary must describe how the research proposal is in alignment with the objectives and research areas of this funding opportunity. Note that your summary cannot exceed 3,500 characters (including spaces) or approximately one (1) page.

• You must indicate your intention to apply for co-funding through another GACD partner (if applicable).
  Task: Enter Budget Information

• Complete the Budget Module in ResearchNet for the total requested budget following the task specific instructions outlined in the Grants – Application Guidelines.

• Financial Assistance Requested Details:

  • Provide a detailed budget justification in relation to planned activities and clearly justify all budget items (including cash and cash equivalent contributions, if relevant). Task: Attach Other Application Materials

• Other – attach the following under "Other":

  • Label as: "GACD Stage 2 Application" (mandatory, maximum 3 documents – maximum 99 pages per document): attach the complete GACD Stage 2 application pdf file.

• Indigenous Experience (mandatory for applications involving Indigenous Peoples, **maximum 1 document) – label as "Indigenous Experience – Name":**

  • For applications involving Indigenous Peoples in Canada and, if applicable, in each country where Indigenous Health Research will be conducted, teams must include at least one team member from each country who self-identifies as Indigenous (In Canada, First Nations, Inuit or Métis) or provides evidence of having meaningful and culturally safe involvement with Indigenous Peoples, or both (see Eligibility 7a).The team must therefore submit a one (1)-page attachment per country describing how they meet this requirement.

• Label as: "Suggested Reviewers" (mandatory, maximum 1 document):

  • In table format, provide a minimum of five suggested reviewers who have relevant expertise to review your proposed work and who would not be in conflict of interest with your application. Include their full name, country, affiliation, and current email address.

• Applicant Partner COI Document (required if applicable): Describe the role of all applicant partners, how/if they will contribute to research and research related activities, and any consideration of risk and/or conflict of interest as appropriate (Maximum 1-page).
  Participant Table (mandatory) – upload as "Participant Table"

• Download and complete the Participant Table for all applicant team members (including Collaborators).

• You must indicate your intention to apply for co-funding through another GACD partner (if applicable).
  Letters of Support (optional):

• Signed letters of support from the community are encouraged. Please review the Writing Letters of Support document for guidance.
  Task: Identify Application Partners (required if applicable) – Upload Partner Information

• A "Partnership Details" form must be submitted for each partner providing cash and/or cash equivalent contributions.

• For each partner, upload a signed "Partner Letter" describing their role, activities, authorities, accountabilities and contributions (including intellectual, financial [cash or cash equivalent] and other resources).
  Task: Apply to Priority Announcements/Funding Pools (mandatory)

• Select the funding opportunity title under the "Priority Announcement/Funding Pool Title" drop-down list, then select the Research Area under the "Relevant Research Area" drop-down list: 1) ICRH Pool and/or 2) IPPH Pool

  • Funding pools should be selected based on priority order (i.e., most relevant under funding pool number 1).

• The information in your Relevance Form must clearly describe (in one half-page) how the objectives of your proposed activity align with the selected funding pool(s). A separate Relevance Form will be required for each funding pool selected.
  Task: Manage Access (optional)

• The Nominated Principal Applicant (NPA) can delegate access to a maximum of five individuals to support the completion of the application. Note: A delegate's access does not carry over from one stage of the competition to another (i.e., from the registration to the application stage). The NPA will need to delegate access at each stage of a competition. NPAs should revoke delegates' access prior to completing the Consent and Submit tasks if they do not want them to retain access to submitted applications via their Completed Activities tab. For more information, please see the Frequently Asked Questions (FAQ).
  Task: Print Signature Page

• Signature Requirements:

  • Signature of the Nominated Principal Applicant is not required for applications submitted through ResearchNet.
  • Signatures must be included for all other applicants (except Collaborators), and individual(s) with signing authority from the Institution Paid.
  • Original signatures are not required. The scanned signed signature pages and the Routing Slip must be uploaded in the Print/Upload Signature Pages task in ResearchNet prior to submitting your application.

Top

---

Contact Information

CIHR Contact Centre
Telephone: 613-954-1968
Toll Free: 1-888-603-4178
Email: support-soutien@cihr-irsc.gc.ca

For service hours, please consult our CIHR Contact Centre page.

Top

---

Sponsor Description

Internal Collaborators

Canadian Institutes of Health Research
At the Canadian Institutes of Health Research (CIHR), we know that research has the power to change lives. As Canada's health research investment agency, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.

CIHR – Institute of Population and Public Health (IPPH)
The mandate of the Institute of Population and Public Health (IPPH) is to support research into the complex biological, social, cultural and environmental interactions that determine the health of individuals, communities and global populations; and to apply knowledge to improve the health of individuals and populations through strategic partnerships with population and public health stakeholders and innovative research funding programs. IPPH's mission aims to improve the health of populations and promote health equity in Canada and globally through research and its application to policies, programs, and practice in public health and other sectors.

CIHR – Institute of Circulatory and Respiratory Health (ICRH) The Institute of Circulatory and Respiratory Health (ICRH) supports research into the causes, mechanisms, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions associated with the heart, lung, brain (stroke), blood, blood vessels, critical and intensive care, and sleep. The ICRH's vision is to deliver better outcomes for Canadians through research and evidence-informed decision-making, across the lifespan, along the full continuum of care, from pre-acute and acute through to post-acute stages.

Top

---

Additional Information

CIHR encourages proposals to adopt the Equity-Centered Principles for Global Health Research: authentic partnering, inclusion, shared benefits, commitment to the future, responsiveness to causes of inequities, and humility that all encourage researchers and others involved to adopt more ethical and equitable forms of global health research.

Top

• Search Again

• Back to Results

• Print Preview Opens in a new window

• Watch this Opportunity

• Notify a Colleague
  Date Modified:

20260226.1